RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 45-55
  • Allergan says it 'will carefully review' Valeant offer

    Allergan Inc., the Irvine company that makes popular wrinkle treatment Botox, acknowledged Tuesday that it has received a buyout offer from Valeant Pharmaceuticals International Inc. The company said the offer from the Canadian drug maker was...
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
  • Ackman and Valeant make bid for Allergan

    Ackman and Valeant make bid for Allergan
    Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment. Valeant will...
  • Ackman, Valeant partnering in bid to acquire Botox maker Allergan

    Activist investor Bill Ackman is partnering with Valeant Pharmaceuticals in an attempt to buy Orange County pharmaceutical company Allergan Inc., which sells the popular wrinkle treatment Botox. Ackman’s Pershing Square Capital Management said...
  • Allergan adopts 'poison pill' defense in Valeant takeover bid

    Allergan Inc., the Irvine company that makes Botox, has adopted a "poison pill" defense that could make it more difficult for Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman to force through a takeover bid....
  • 800-GET-THIN surgery centers sue insurer over Lap-Band payments

    800-GET-THIN surgery centers sue insurer over Lap-Band payments
    Ten Southern California surgery centers once affiliated with the defunct 1-800-GET-THIN advertising campaign are suing UnitedHealth Group Inc. to get reimbursed for hundreds of Lap-Band weight-loss procedures. The lawsuit comes amid federal and state...
  • Allergan stock climbs amid $46-billion bid

    Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....
  • Ackman, Valeant partner in bid to buy Botox maker Allergan

    Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox. Ackman and Valeant Pharmaceuticals International Inc. have already...
  • Allergan adopts 'poison pill' defense in Valeant takeover bid

    Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman. The Irvine company's...
  • Developer plans walkable neighborhood in Newport Beach

    Newport Beach, one of Southern California's most affluent cities, is about to transform an industrial area near John Wayne Airport into a distinctly urban community of homes and shops. Uptown Newport Village will replace a pair of aging industrial...
  • The day ahead in business

    The day ahead in business
    Reports: Jan ADP survey for January, weekly mortgage applications, January ISM Local earnings: Allstate Corp., Littelfuse Inc., Stericycle Inc., Walgreen Co. Other earnings: Allergan Inc., Automatic Data Processing Inc., Mercks & Co., Nasdaq OMX Group,...